Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

Background: Bradykinin angioedemas are a potentially serious side effect of angiotensin-converting enzyme inhibitors (ACEI) and more controversially of angiotensin II receptor blockers (ARB). Their challenging diagnosis is based on the absence of any recurrence after more than 6 months of drug disco...

Full description

Bibliographic Details
Main Authors: Marie Douillard, MD, Zineb Deheb, MD, Agathe Bozon, MD, Nadia Raison-Peyron, MD, Olivier Dereure, MD, PhD, Lionel Moulis, MD, Angèle Soria, MD, PhD, Aurélie Du-Thanh, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:World Allergy Organization Journal
Subjects:
Angioedema
Bradykinin
Mast-cell
Angiotensin converting enzyme inhibitors
Urticaria
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123000698

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123000698

Similar Items